Home › twoXAR Joins Stanford University In Hunt For Medicines Targeting Rare Diseases
 

Keywords :   


twoXAR Joins Stanford University In Hunt For Medicines Targeting Rare Diseases

2016-05-03 03:04:31| drugdiscoveryonline News Articles

twoXAR, Inc., a company dedicated to improving health through computation, recently announced a collaboration with Joyce Teng, MD, PhD, of the Department of Dermatology at Stanford University to support research focused on the identification of drug candidates targeting rare disorders such as lymphatic malformation and epidermolysis bullosa simplex (EBS)

Tags: university rare diseases hunt

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.06Hurricane Beryl Public Advisory Number 8A
30.06Hurricane Beryl Graphics
30.06Eastern North Pacific Tropical Weather Outlook
30.06Atlantic Tropical Weather Outlook
30.06Hurricane Beryl Update Statement
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Forecast Discussion Number 8
More »